NORTHWESTERN MEDICINE RHEUMATOLOGY
​ACR 2023 PRESENTATIONS AND ABSTRACTS

Irene Blanco, MD, MS

The Impact of the Diversification of the Biomedical Workforce
Sunday, November 12
12:30 – 12:50 pm
 
Impact of Health Disparities in Rheumatology
Monday, November 13
9:15 – 9:30 am
 
Assessing Social and Structural Competence in Medical Education: Where Are We Today?
Monday, November 13
4:00 – 4:20 pm
Carla M. Cuda, PhD

Specificity of Brain-Intrinsic and Hematopoietic-Derived Mechanisms in Mediating Neuropsychiatric Symptoms of Systemic Lupus Erythematosus
Monday, November 13
9:00 – 11:00 am
 
Microglia in Central Nervous System Lupus
Monday, November 13
2:30 – 2:45 pm
 
Abstracts: SLE – Animal Models
Tuesday, November 14
2:00 – 3:30 pm
Matthew Dapas, PhD

Mapping Cellular Landscape of Esophageal Epithelium in Systemic Sclerosis Using Single-cell Transcriptomics
Sunday, November 12
9:00 – 11:00 am 
Anisha B. Dua, MD

Clinician Educator Career I
Friday, November 10
3:45 – 4:05 pm
 
Efficacy and Safety of Avacopan in Patients with ANCA-Associated Vasculitis Receiving Rituximab in a Phase 3 Trial
Sunday, November 12
9:00 – 11:00 am
 
Abstracts: Professional Education
Sunday, November 12
2:00 – 3:30 pm 
 
Eosinophilic Granulomatosis with Polyangiitis: Beyond Evidence-Based Medicine
Monday, November 13
4:00 – 4:20 pm
 
The Transition from Residency to Fellowship: Enhancing Training by Increasing Transparency
Tuesday, November 14
7:45 – 8:00 am 
Hadijat Makinde, PhD

Abstracts: RA – Animal Models
Sunday, November 12
4:00 – 5:30 pm
 
Investigating Macrophage Heterogeneity in the Esophagus of SSc Patients
Tuesday, November 14
9:00 – 11:00 am
Arthur M. Mandelin, MD, PhD

ACR Musculoskeletal Ultrasound Guidance Update for Soft Tissue Disorders and Procedures
Monday, November 13
7:30 – 8:30 am
 
Ultrasound Guided Synovial Biopsy Course: Achievement of Learner Self Efficacy
Tuesday, November 14
9:00 – 11:00 am
Rosalind Ramsey-Goldman, MD, DrPH

Interventions to Increase Minority Participation in Lupus Clinical Trials
Sunday, November 12
Noon – 1:00 pm
 
Reproductive Issues in Rheumatic Disorders Poster II
Monday, November 13
9:00 – 11:00 am
Damini Jawaheer, PhD, MS

Pre-pregnancy Gene Expression Signatures Among Women with Rheumatoid Arthritis May Represent Predictive Biomarkers for Subsequent Improvement or Worsening During Pregnancy
Tuesday, November 14
2:30 – 2:40 pm 
Yvonne Lee, MD, MMSc

Focus on Specific Rheumatic and Musculoskeletal Diseases (RMDs) Part 1: Rheumatoid Arthritis – Clinical Insights
Saturday, November 11
11:30 – 11:45 am
 
Sleep Disturbance Predicts Pain Interference in Patients with Early Rheumatoid Arthritis in a Prospective Real-World Cohort
Sunday, November 12
4:00 – 5:30 pm
Carrie Richardson, MD

Abstracts: Miscellaneous Rheumatic & Inflammatory Diseases
Sunday, November 12
2:00 – 3:30 pm
Thomas J. Schnitzer, MD, PhD

Efficacy and Safety of a Single Intra-Articular Injection of MM-II, a Novel Suspension of Large, Empty, Multilamellar Liposomes, in People with Painful Knee OA: Results of a 26-Week, Phase 2b, Placebo-Controlled, Double-Blind, Randomized Trial
Monday, November 13
9:00 – 11:00 am

​NORTHWESTERN MEDICINE RHEUMATOLOGY

The Division of Rheumatology promotes prevention, cure and relief of suffering caused by arthritis and rheumatic diseases through research, education and patient care. Our diverse faculty are world-renowned experts in all spectrums of rheumatic disease including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, osteoarthritis, scleroderma, systemic lupus erythematosus, gout, myositis and vasculitis. Our scleroderma and vasculitis clinical programs are among the largest in the nation.

​We are one of the few rheumatology programs in the country that has a dedicated ultrasound-imaging clinic, which maintains the state-of-the-art equipment as well as being the center for experimental procedures such as ultrasound-guided synovial biopsies. The central focus of our research is predicated on being transformative, translational and collaborative. Our projects center on providing better treatments for our patients, identifying new therapeutics or the underlying basis of disease, and establishing a precision medicine approach. ​